861 related articles for article (PubMed ID: 9841098)
1. [Estrogens, cathepsin D and metastasis in cancers of the breast and ovary: invasion or proliferation?].
Rochefort H
C R Seances Soc Biol Fil; 1998; 192(2):241-51. PubMed ID: 9841098
[TBL] [Abstract][Full Text] [Related]
2. Biological and clinical significance of cathepsin D in breast cancer metastasis.
Garcia M; Platet N; Liaudet E; Laurent V; Derocq D; Brouillet JP; Rochefort H
Stem Cells; 1996 Nov; 14(6):642-50. PubMed ID: 8948022
[TBL] [Abstract][Full Text] [Related]
3. Estrogen receptor mediated inhibition of cancer cell invasion and motility: an overview.
Rochefort H; Platet N; Hayashido Y; Derocq D; Lucas A; Cunat S; Garcia M
J Steroid Biochem Mol Biol; 1998 Apr; 65(1-6):163-8. PubMed ID: 9699869
[TBL] [Abstract][Full Text] [Related]
4. [Estrogen-induced genes in breast cancer, and their medical importance].
Rochefort H
Bull Acad Natl Med; 1999; 183(5):955-68; discussion 968-71. PubMed ID: 10465000
[TBL] [Abstract][Full Text] [Related]
5. In vitro degradation of extracellular matrix with Mr 52,000 cathepsin D secreted by breast cancer cells.
Briozzo P; Morisset M; Capony F; Rougeot C; Rochefort H
Cancer Res; 1988 Jul; 48(13):3688-92. PubMed ID: 3378211
[TBL] [Abstract][Full Text] [Related]
6. [Mechanism of the overexpression of the cathepsin D gene in breast cancer and consequences in the metastatic process].
Rochefort H
C R Seances Soc Biol Fil; 1991; 185(6):415-21. PubMed ID: 1822391
[TBL] [Abstract][Full Text] [Related]
7. Comparison of hyaluronidase expression, invasiveness and tubule formation promotion in ER (-) and ER (+) breast cancer cell lines in vitro.
Wang XY; Tan JX; Vasse M; Delpech B; Ren GS
Chin Med J (Engl); 2009 Jun; 122(11):1300-4. PubMed ID: 19567141
[TBL] [Abstract][Full Text] [Related]
8. [Angiogenic effect of interleukin-8 in breast cancer and its association with estrogen receptor].
Lin Y; Wang SM; Huang RP
Zhonghua Yi Xue Za Zhi; 2005 Jun; 85(20):1419-23. PubMed ID: 16029657
[TBL] [Abstract][Full Text] [Related]
9. Down-regulation of cathepsin-D expression by antisense gene transfer inhibits tumor growth and experimental lung metastasis of human breast cancer cells.
Glondu M; Liaudet-Coopman E; Derocq D; Platet N; Rochefort H; Garcia M
Oncogene; 2002 Aug; 21(33):5127-34. PubMed ID: 12140763
[TBL] [Abstract][Full Text] [Related]
10. Cathepsin-D and c-erb-B 2 have an additive prognostic value for breast cancer patients.
Scorilas A; Yotis J; Gouriotis D; Keramopoulos A; Ampela K; Trangas T; Talieri M
Anticancer Res; 1993; 13(5C):1895-900. PubMed ID: 7903524
[TBL] [Abstract][Full Text] [Related]
11. A metastatic breast tumor cell line, GI-101A, is estrogen receptor positive and responsive to estrogen but resistant to tamoxifen.
Morrissey JJ; Raney S
Cell Biol Int; 1998; 22(6):413-9. PubMed ID: 10328849
[TBL] [Abstract][Full Text] [Related]
12. Association of increased basement membrane invasiveness with absence of estrogen receptor and expression of vimentin in human breast cancer cell lines.
Thompson EW; Paik S; BrĂ¼nner N; Sommers CL; Zugmaier G; Clarke R; Shima TB; Torri J; Donahue S; Lippman ME
J Cell Physiol; 1992 Mar; 150(3):534-44. PubMed ID: 1537883
[TBL] [Abstract][Full Text] [Related]
13. A mutated cathepsin-D devoid of its catalytic activity stimulates the growth of cancer cells.
Glondu M; Coopman P; Laurent-Matha V; Garcia M; Rochefort H; Liaudet-Coopman E
Oncogene; 2001 Oct; 20(47):6920-9. PubMed ID: 11687971
[TBL] [Abstract][Full Text] [Related]
14. Reduction of human metastatic breast cancer cell aggressiveness on introduction of either form a or B of the progesterone receptor and then treatment with progestins.
Sumida T; Itahana Y; Hamakawa H; Desprez PY
Cancer Res; 2004 Nov; 64(21):7886-92. PubMed ID: 15520195
[TBL] [Abstract][Full Text] [Related]
15. Role of interleukin-8 in the progression of estrogen receptor-negative breast cancer.
Yao C; Lin Y; Ye CS; Bi J; Zhu YF; Wang SM
Chin Med J (Engl); 2007 Oct; 120(20):1766-72. PubMed ID: 18028768
[TBL] [Abstract][Full Text] [Related]
16. Metastasis tumor antigen family proteins during breast cancer progression and metastasis in a reliable mouse model for human breast cancer.
Zhang H; Stephens LC; Kumar R
Clin Cancer Res; 2006 Mar; 12(5):1479-86. PubMed ID: 16533771
[TBL] [Abstract][Full Text] [Related]
17. The estrogenic activity of synthetic progestins used in oral contraceptives enhances fatty acid synthase-dependent breast cancer cell proliferation and survival.
Menendez JA; Oza BP; Colomer R; Lupu R
Int J Oncol; 2005 Jun; 26(6):1507-15. PubMed ID: 15870863
[TBL] [Abstract][Full Text] [Related]
18. Effects of pharmacological concentrations of estrogens on proliferation and cell cycle kinetics of human breast cancer cell lines in vitro.
Reddel RR; Sutherland RL
Cancer Res; 1987 Oct; 47(20):5323-9. PubMed ID: 3652038
[TBL] [Abstract][Full Text] [Related]
19. Estrogens and epithelial ovarian cancer.
Cunat S; Hoffmann P; Pujol P
Gynecol Oncol; 2004 Jul; 94(1):25-32. PubMed ID: 15262115
[TBL] [Abstract][Full Text] [Related]
20. The p160 family coactivators regulate breast cancer cell proliferation and invasion through autocrine/paracrine activity of SDF-1alpha/CXCL12.
Kishimoto H; Wang Z; Bhat-Nakshatri P; Chang D; Clarke R; Nakshatri H
Carcinogenesis; 2005 Oct; 26(10):1706-15. PubMed ID: 15917309
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]